找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Cancer Gene Therapy; David T. Curiel,Joanne T. Douglas Book 2005 Humana Press 2005 cancer treatment.clinical trial.gene therapy.gene trans

[復(fù)制鏈接]
51#
發(fā)表于 2025-3-30 11:08:49 | 只看該作者
52#
發(fā)表于 2025-3-30 13:50:15 | 只看該作者
53#
發(fā)表于 2025-3-30 18:49:27 | 只看該作者
A. Bonso,A. Rossillo,R. Valente,A. Ravieleto the bedside. Between 1994 and the end of 2002, more than 25 clinical trials for TSG replacement therapy were initiated, and results indicated a promising future for TSG in the management of cancer.
54#
發(fā)表于 2025-3-30 21:28:27 | 只看該作者
New Advances in Histamine Researchnuclear (sn)RNAs as a ribozyme in complex with the premessenger RNA (pre-mRNA) to catalyze pre-mRNA splicing has also been proposed .. It is highly likely that additional RNA catalytic motifs and new roles for RNA-mediated catalysis will also be found as more is learned about the genomes of a variet
55#
發(fā)表于 2025-3-31 02:21:02 | 只看該作者
Book 2005cancer genes and gene delivery methods currently available for cancer gene therapy, including the transfer of genetic material into the cancer cells, stimulation of the immune system to recognize and eliminate cancer cells, and the targeting of the nonmalignant stromal cells that support their growt
56#
發(fā)表于 2025-3-31 06:57:48 | 只看該作者
57#
發(fā)表于 2025-3-31 11:14:32 | 只看該作者
58#
發(fā)表于 2025-3-31 14:09:43 | 只看該作者
59#
發(fā)表于 2025-3-31 20:06:07 | 只看該作者
https://doi.org/10.1007/978-88-470-2087-0 technologies in this field. For the purpose of this chapter, we use . to refer to the classical antisense approach. Other chapters in this book provide further information and discussions on ribozyme and aptamer approaches (. Chapter 5).
60#
發(fā)表于 2025-4-1 00:57:35 | 只看該作者
Antiphospholipid Syndrome Risk Evaluationnatives aimed at enhancing the selectivity of cancer chemotherapy for solid tumors rely on targeting cancer cells with chemoimmunoconjugates, antibody-directed enzyme prodrug therapy (ADEPT) ., or gene-directed enzyme prodrug therapy (GDEPT) ..
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-7 07:44
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
泸水县| 得荣县| 南城县| 封丘县| 灵石县| 安多县| 公主岭市| 疏勒县| 田阳县| 腾冲县| 大丰市| 吴江市| 普陀区| 吴桥县| 张家川| 杂多县| 双柏县| 长沙市| 同江市| 彩票| 江孜县| 田林县| 洪洞县| 华阴市| 龙山县| 信宜市| 荣成市| 永春县| 三台县| 武宁县| 筠连县| 五家渠市| 白朗县| 大竹县| 衢州市| 阿瓦提县| 牙克石市| 蒙山县| 广西| 政和县| 英山县|